Skip to main content
Top
Published in: Drugs & Aging 9/2013

01-09-2013 | Therapy in Practice

Diagnosis and Management of the Patient with Suspected Dementia in Primary Care

Authors: Stefan Holzer, James P. Warner, Steve Iliffe

Published in: Drugs & Aging | Issue 9/2013

Login to get access

Abstract

Dementia is a complex progressive syndrome characterised by impairment of cognition (including memory, language, visuospatial skills and executive function), changes in personality and diminished activities of daily living. The impact of dementia is enormous and poses a huge challenge to patients, their carers, society at large and health systems around the world, in terms of the direct cost of medical care, social care and unpaid care provided by family members and others. In this review, we combine evidence and clinical opinion, using guidelines and reviews from 2006, 2009 and 2010 to present a practical guide for primary care physicians to the diagnosis, treatment and ongoing care of patients with suspected or diagnosed dementia. This review summarises the epidemiology of dementia syndrome, and offers detailed evidence-based advice on recognition of dementia (including subtyping) and responses to it and its associated symptoms. The roles of neuroimaging and biomarkers are discussed, as are both non-pharmacological and pharmacological therapies.
Literature
3.
go back to reference Dixon-Woods M, Cavers D, Agarwal S, et al. Conducting a critical interpretive synthesis of the literature on access to healthcare by vulnerable groups. BMC Med Res Methodol. 2006;6:35.PubMedCrossRef Dixon-Woods M, Cavers D, Agarwal S, et al. Conducting a critical interpretive synthesis of the literature on access to healthcare by vulnerable groups. BMC Med Res Methodol. 2006;6:35.PubMedCrossRef
4.
go back to reference NICE/SCIE dementia clinical guidelines. National Institute for Health and Clinical Excellence, 2006. NICE/SCIE dementia clinical guidelines. National Institute for Health and Clinical Excellence, 2006.
5.
go back to reference Iliffe S, Robinson L, Brayne C, et al. Primary care & dementia: 1 diagnosis, screening and disclosure. Int J Geriatric Psychiatr. 2009;24(9):895–901.CrossRef Iliffe S, Robinson L, Brayne C, et al. Primary care & dementia: 1 diagnosis, screening and disclosure. Int J Geriatric Psychiatr. 2009;24(9):895–901.CrossRef
6.
go back to reference Robinson L, Iliffe S, Brayne C, et al. Primary care & dementia: 2 case management, carer support & the management of behavioural and psychological symptoms. Int J Geriatr Psychiatr. 2010;25(7):657–64.CrossRef Robinson L, Iliffe S, Brayne C, et al. Primary care & dementia: 2 case management, carer support & the management of behavioural and psychological symptoms. Int J Geriatr Psychiatr. 2010;25(7):657–64.CrossRef
7.
go back to reference O’Brien J, Burns A on behalf of the BAP Dementia Consensus Group Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology. Psychopharmacology. 2010. doi: 10.1177/0269881110387547. O’Brien J, Burns A on behalf of the BAP Dementia Consensus Group Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology. Psychopharmacology. 2010. doi: 10.​1177/​0269881110387547​.
9.
go back to reference World Alzheimer’s Report 2009. Alzheimer’s Disease International, London. 2009. World Alzheimer’s Report 2009. Alzheimer’s Disease International, London. 2009.
10.
go back to reference World Health Organization. Dementia: a public health priority. World Health Organization 2012. World Health Organization. Dementia: a public health priority. World Health Organization 2012.
12.
go back to reference Villars H, Oustric S, Andrieu S, et al. The primary care physician and Alzheimer’s disease: an international position paper. J Nutr Health Aging. 2010;14(2):110–20.PubMedCrossRef Villars H, Oustric S, Andrieu S, et al. The primary care physician and Alzheimer’s disease: an international position paper. J Nutr Health Aging. 2010;14(2):110–20.PubMedCrossRef
16.
go back to reference Vernooij-Dassen MJFJ, Moniz-Cook ED, Woods RT, De Lepeleire J, Leuschner A, Zanetti O, et al. Factors affecting timely recognition and diagnosis of dementia across Europe: from awareness to stigma. Int J Geriatr Psychiatry [Internet]. 2005 Apr [cited 2012 Oct 16]; 20(4):377–86. http://www.ncbi.nlm.nih.gov/pubmed/15799080. Vernooij-Dassen MJFJ, Moniz-Cook ED, Woods RT, De Lepeleire J, Leuschner A, Zanetti O, et al. Factors affecting timely recognition and diagnosis of dementia across Europe: from awareness to stigma. Int J Geriatr Psychiatry [Internet]. 2005 Apr [cited 2012 Oct 16]; 20(4):377–86. http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​15799080.
24.
go back to reference Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dementia [Internet]. 2011 May [cited 2012 Mar 8]; 7(3):270–79. http://www.ncbi.nlm.nih.gov/pubmed/21514249. Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dementia [Internet]. 2011 May [cited 2012 Mar 8]; 7(3):270–79. http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​21514249.
29.
32.
go back to reference Genius J, Klafki H, Benninghoff J, Esselmann H, Wiltfang J. Current application of neurochemical biomarkers in the prediction and differential diagnosis of Alzheimer’s disease and other neurodegenerative dementias. Eur Archives Psychiatry Clin Neurosci [Internet]. 2012 Nov [cited 2013 Jan 12]; 262 Suppl 2:S71–77. http://www.ncbi.nlm.nih.gov/pubmed/22986448. Genius J, Klafki H, Benninghoff J, Esselmann H, Wiltfang J. Current application of neurochemical biomarkers in the prediction and differential diagnosis of Alzheimer’s disease and other neurodegenerative dementias. Eur Archives Psychiatry Clin Neurosci [Internet]. 2012 Nov [cited 2013 Jan 12]; 262 Suppl 2:S71–77. http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​22986448.
37.
go back to reference Warner JP, Butler R, Gupta S. Dementia Clin Evid [Online]. [cited 2010 Apr 8]; pii:1001 Warner JP, Butler R, Gupta S. Dementia Clin Evid [Online]. [cited 2010 Apr 8]; pii:1001
44.
go back to reference Howard R, McShane R, Lindesay J, et al. Donepezil and memantine for moderate-to-severe Alzheimer’s disease. N Engl J Med. 2012;366:893–903.PubMedCrossRef Howard R, McShane R, Lindesay J, et al. Donepezil and memantine for moderate-to-severe Alzheimer’s disease. N Engl J Med. 2012;366:893–903.PubMedCrossRef
45.
go back to reference Salib E, Thompson J. Use of anti-dementia drugs and delayed care home placement: an observational study (PDF). Psychiatrist. 2011;35:384–8.CrossRef Salib E, Thompson J. Use of anti-dementia drugs and delayed care home placement: an observational study (PDF). Psychiatrist. 2011;35:384–8.CrossRef
46.
go back to reference Danysz W, Parsons CG. The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer’s disease: preclinical evidence. Int J Geriatr Psychiatry [Internet]. 2003 Sep [cited 2012 May 7]; 18(S1):S23–32. http://doi.wiley.com/10.1002/gps.938. Danysz W, Parsons CG. The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer’s disease: preclinical evidence. Int J Geriatr Psychiatry [Internet]. 2003 Sep [cited 2012 May 7]; 18(S1):S23–32. http://​doi.​wiley.​com/​10.​1002/​gps.​938.
Metadata
Title
Diagnosis and Management of the Patient with Suspected Dementia in Primary Care
Authors
Stefan Holzer
James P. Warner
Steve Iliffe
Publication date
01-09-2013
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 9/2013
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.1007/s40266-013-0098-4

Other articles of this Issue 9/2013

Drugs & Aging 9/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.